YOLFTbeta
Epsilon Healthcare Ltd

Epsilon Healthcare Ltd

EPN · AU · Healthcare / Drug Manufacturers - Specialty & Generic

0.024AUD+0.00 (+4.35%)

Price History

Full chart

Market Stats

Previous Close0.023
Open0.024
Day Range0.023 – 0.024
52-Week Range0.019 – 0.04
Volume67.89K
Market Cap10.12M
P/E (TTM)0.00
Forward P/E0.00
EPS0.00
Dividend Yield0.00%
Beta0.75
50-Day Avg0.0249
200-Day Avg0.0249

About

Epsilon Healthcare Limited, together with its subsidiaries, engages in the healthcare business in Australia. The company operates in three segments, Contract Development and Manufacturing Activities, Telehealth Medical Practice Services, and Pharmacy Services. It is involved in the healthcare and clinics operation; pharmaceutical contract development and manufacturing; development and manufacturing of active pharmaceutical ingredients and finished formulation; and provision of pharmacy services and patient care. The company was formerly known as THC Global Group Limited and changed its name to Epsilon Healthcare Limited in February 2021. Epsilon Healthcare Limited was incorporated in 2016 and is based in Southport, Australia.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Peter Giannopoulos
  • Employees0
  • Headquarters5 Goodyear Street, Southport, QLD, Australia, 4215, Australia
  • Websitehttps://epsilonhealthcare.com.au

Leadership

  • Mr. Peter GiannopoulosGroup CEO, MD & Executive Director
  • Mr. Daniel KaplonCFO & Company Secretary
  • Ms. Li LinGroup Financial Controller

Financials

Income Statement

Currency: AUD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue01.84M2.66M4.79M6.95M5.50M7.11M6.65M5.60M9.39M
Growth (%)--+44.47%+79.88%+45.09%-20.93%+29.36%-6.48%-15.81%+67.74%
Cost of Revenue01.07M1.90M3.65M4.70M3.44M6.39M1.84M1.43M7.30M
Gross Profit0837.01K-935.89K1.14M-3.82M2.06M725.85K4.81M4.17M2.09M
Gross Margin-45.39%-35.13%23.78%-54.96%37.39%10.21%72.34%74.52%22.28%
Operating Expense207.67K3.33M6.65M10.30M6.97M11.22M8.71M7.23M8.41M4.47M
Operating Income-207.67K-2.50M-7.58M-9.16M-10.80M-9.17M-7.98M-2.42M-4.24M-2.38M
Operating Margin--135.45%-284.59%-191.12%-155.26%-166.75%-112.26%-36.32%-75.72%-25.31%
EBITDA-207.67K-2.52M-8.41M-9.64M-9.20M-8.03M-10.86M-937.07K-2.13M-1.86M
EBITDA Margin--136.88%-315.76%-201.15%-132.35%-145.96%-152.63%-14.09%-38.09%-19.79%
Net Income-212.89K-2.56M-8.61M-11.68M-10.54M-9.24M-13.29M-1.09M-3.25M-1.28M
Net Income Margin--138.75%-323.23%-243.71%-151.51%-168.11%-186.84%-16.40%-57.97%-13.61%
R&D--41.63K140.30K472.26K171.10K375.56K53.75K--
R&D as % of Total Revenue--1.56%2.93%6.79%3.11%5.28%0.81%--
Interest Expense51010.81K84.05K143.70K597.75K870.22K1.36M515.21K1.15M1.26M
Interest Expense % of Total Revenue-0.59%3.16%3.00%8.60%15.83%19.06%7.75%20.55%13.37%

Balance Sheet

Currency: AUD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets11.46M21.95M32.75M27.81M37.26M30.55M20.50M14.41M22.26M17.87M
Total Liabilities116.99K588.83K4.66M5.49M11.94M10.98M11.23M6.87M11.57M15.95M
Total Equity11.34M21.36M28.09M22.32M25.32M19.57M9.27M7.54M10.70M1.91M
Cash3.62M11.04M6.33M3.55M6.97M2.34M861.99K343.01K1.57M242.86K
Total Debt--408.12K711.26K5.11M4.33M3.20M3.45M7.88M10.35M
Net Debt-3.62M-11.04M-5.93M-2.84M-1.86M1.99M2.34M3.11M6.32M10.11M

Cash Flow

Currency: AUD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-147.81K-1.88M-5.85M-7.86M-8.69M-5.39M-2.57M-703.37K-3.41M-3.13M
Investing Cash Flow-114.42K-759.11K-3.06M-714.68K-1.73M-737.59K-529.40K-99.12K-97.73K6.29M
Financing Cash Flow1.15M12.81M4.20M5.78M13.84M1.47M1.61M335.91K4.73M-4.48M
Capital Expenditure0657.92K3.03M714.68K1.24M747.71K529.41K100.09K97.73K169.74K
Free Cash Flow-147.81K-657.92K-8.88M-8.57M-9.93M-6.18M-3.10M-803.47K-3.50M-3.30M
Dividends Paid------4.50M---
FCF to OCF100.00%35.03%151.82%109.10%114.21%114.69%120.59%114.23%102.87%105.43%
Dividend Paid to FCF-------145.03%---

Earnings

Report DateAug 31, 2017Mar 2, 2018Aug 30, 2018Feb 28, 2019Aug 30, 2019Mar 1, 2020Aug 31, 2020Feb 26, 2021Aug 31, 2021Feb 28, 2022Aug 31, 2022Feb 28, 2023Aug 31, 2023May 16, 2025Oct 6, 2025
EPS Estimate0.000.000.000.000.000.000.000.00-0.00-0.000.000.000.00
EPS Actual-0.01-0.02-0.03-0.04-0.04-0.09-0.04-0.03-0.02-0.02-0.04-0.020.000.000.00
Surprise---------------
Timing----------Pre-marketAfter-hours---

Key Statistics & Ratios

Market Cap10.12M
Enterprise Value18.30M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.75
Price / Book2.81
EPS0.00
Book Value0.01
Revenue (TTM)13.58M
Gross Profit (TTM)7.94M
EBITDA-818.48K
Profit Margin0.47%
Operating Margin-15.78%
Return on Equity50.27%
Return on Assets-5.29%
Shares Outstanding389.10M
Shares Float241.88M
Beta0.75
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%